TY - JOUR AU - Akiyama, T. AU - Sudo, C. AU - Ogawara, H. AU - Toyoshima, K. AU - Yamamoto, T. PY - 1986 DA - 1986// TI - The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity JO - Science VL - 232 UR - https://doi.org/10.1126/science.3012781 DO - 10.1126/science.3012781 ID - Akiyama1986 ER - TY - JOUR AU - Yarden, Y. AU - Sliwkowski, M. X. PY - 2001 DA - 2001// TI - Untangling the ErbB signalling network JO - Nat Rev Mol Cell Biol VL - 2 UR - https://doi.org/10.1038/35052073 DO - 10.1038/35052073 ID - Yarden2001 ER - TY - JOUR AU - Klapper, L. N. AU - Kirschbaum, M. H. AU - Sela, M. AU - Yarden, Y. PY - 2000 DA - 2000// TI - Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors JO - Adv Cancer Res VL - 77 UR - https://doi.org/10.1016/S0065-230X(08)60784-8 DO - 10.1016/S0065-230X(08)60784-8 ID - Klapper2000 ER - TY - JOUR AU - Disis, M. L. AU - Calenoff, E. AU - McLaughlin, G. AU - Murphy, A. E. AU - Chen, W. AU - Groner, B. AU - Jeschke, M. AU - Lydon, N. AU - McGlynn, E. AU - Livingston, R. B. PY - 1994 DA - 1994// TI - Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer JO - Cancer Res VL - 54 ID - Disis1994 ER - TY - JOUR AU - Chen, Y. AU - Hu, D. AU - Eling, D. J. AU - Robbins, J. AU - Kipps, T. J. PY - 1998 DA - 1998// TI - DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors JO - Cancer Res VL - 58 ID - Chen1998 ER - TY - JOUR AU - Jasinska, J. AU - Wagner, S. AU - Radauer, C. AU - Sedivy, R. AU - Brodowicz, T. AU - Wiltschke, C. AU - Breiteneder, H. AU - Pehamberger, H. AU - Scheiner, O. AU - Wiedermann, U. PY - 2003 DA - 2003// TI - Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her-2/neu JO - Int J Cancer VL - 107 UR - https://doi.org/10.1002/ijc.11485 DO - 10.1002/ijc.11485 ID - Jasinska2003 ER - TY - JOUR AU - Cornet, S. AU - Miconnet, I. AU - Menez, J. AU - Lemonnier, F. AU - Kosmatopoulos, K. PY - 2006 DA - 2006// TI - Optimal organization of a polypeptide-based candidate cancer vaccine composed of cryptic tumor peptides with enhanced immunogenicity JO - Vaccine VL - 24 UR - https://doi.org/10.1016/j.vaccine.2005.11.015 DO - 10.1016/j.vaccine.2005.11.015 ID - Cornet2006 ER - TY - JOUR AU - Gritzapis, A. D. AU - Mahaira, L. G. AU - Perez, S. A. AU - Cacoullos, N. T. AU - Papamichail, M. AU - Baxevanis, C. N. PY - 2006 DA - 2006// TI - Vaccination with human HER-2/neu (435-443) CTL peptide induces effective antitumor immunity against HER-2/neu-expressing tumor cells in vivo JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-4018 DO - 10.1158/0008-5472.CAN-05-4018 ID - Gritzapis2006 ER - TY - JOUR AU - Taylor, P. AU - Gerder, M. AU - Moros, Z. AU - Feldmann, M. PY - 1996 DA - 1996// TI - Humoral and cellular responses raised against the human HER2 oncoprotein are cross-reactive with the homologous product of the new proto-oncogene, but do not protect rats against B104 tumors expressing mutated neu JO - Cancer Immunol Immunother VL - 42 UR - https://doi.org/10.1007/s002620050268 DO - 10.1007/s002620050268 ID - Taylor1996 ER - TY - JOUR AU - Foy, T. M. AU - Bannink, J. AU - Sutherland, R. A. AU - McNeill, P. D. AU - Moulton, G. G. AU - Smith, J. AU - Cheever, M. A. AU - Grabstein, K. PY - 2001 DA - 2001// TI - Vaccination with Her-2/neu DNA or protein subunits protects against growth of a Her-2/neu-expressing murine tumor JO - Vaccine VL - 19 UR - https://doi.org/10.1016/S0264-410X(00)00493-X DO - 10.1016/S0264-410X(00)00493-X ID - Foy2001 ER - TY - JOUR AU - Dela Cruz, J. S. AU - Lau, S. Y. AU - Ramirez, E. M. AU - De Giovanni, C. AU - Forni, G. AU - Morrison, S. L. AU - Penichet, M. L. PY - 2003 DA - 2003// TI - Protein vaccination with the HER2/neu extracellular domain plus anti-HER2/neu antibody-cytokine fusion proteins induces a protective anti-HER2/neu immune response in mice JO - Vaccine VL - 21 UR - https://doi.org/10.1016/S0264-410X(02)00741-7 DO - 10.1016/S0264-410X(02)00741-7 ID - Dela Cruz2003 ER - TY - JOUR AU - Vidovic, D. AU - Graddis, T. AU - Chen, F. AU - Slagle, P. AU - Diegel, M. AU - Stepan, L. AU - Laus, R. PY - 2002 DA - 2002// TI - Antitumor vaccination with HER-2-derived recombinant antigens JO - Int J Cancer VL - 102 UR - https://doi.org/10.1002/ijc.10785 DO - 10.1002/ijc.10785 ID - Vidovic2002 ER - TY - JOUR AU - Apostolopoulos, V. AU - McKenzie, I. F. PY - 2001 DA - 2001// TI - Role of the mannose receptor in the immune response JO - Curr Mol Med VL - 1 UR - https://doi.org/10.2174/1566524013363645 DO - 10.2174/1566524013363645 ID - Apostolopoulos2001 ER - TY - JOUR AU - Lam, J. S. AU - Mansour, M. K. AU - Specht, C. A. AU - Levitz, S. M. PY - 2005 DA - 2005// TI - A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity JO - J Immunol VL - 175 UR - https://doi.org/10.4049/jimmunol.175.11.7496 DO - 10.4049/jimmunol.175.11.7496 ID - Lam2005 ER - TY - JOUR AU - Luong, M. AU - Lam, J. S. AU - Chen, J. AU - Levitz, S. M. PY - 2007 DA - 2007// TI - Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines JO - Vaccine VL - 25 UR - https://doi.org/10.1016/j.vaccine.2007.03.027 DO - 10.1016/j.vaccine.2007.03.027 ID - Luong2007 ER - TY - JOUR AU - Pascolo, S. AU - Bervas, N. AU - Ure, J. M. AU - Smith, A. G. AU - Lemonnier, F. A. AU - Perarnau, B. PY - 1997 DA - 1997// TI - HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2 m) HLA-A2.1 monochain transgenic H-2Db beta2 m double knockout mice JO - J Exp Med VL - 185 UR - https://doi.org/10.1084/jem.185.12.2043 DO - 10.1084/jem.185.12.2043 ID - Pascolo1997 ER - TY - JOUR AU - Piechocki, M. P. AU - Pilon, S. A. AU - Kelly, C. AU - Wei, W. Z. PY - 2001 DA - 2001// TI - Degradation signals in ErbB-2 dictate proteasomal processing and immunogenicity and resist protection by cis glycine-alanine repeat JO - Cell Immunol VL - 212 UR - https://doi.org/10.1006/cimm.2001.1853 DO - 10.1006/cimm.2001.1853 ID - Piechocki2001 ER - TY - JOUR AU - Belimezi, M. M. AU - Papanastassiou, D. AU - Merkouri, E. AU - Baxevanis, C. N. AU - Mamalaki, A. PY - 2006 DA - 2006// TI - Growth inhibition of breast cancer cell lines overexpressing Her2/neu by a novel internalized fully human Fab antibody fragment JO - Cancer Immunol Immunother VL - 55 UR - https://doi.org/10.1007/s00262-005-0100-z DO - 10.1007/s00262-005-0100-z ID - Belimezi2006 ER - TY - JOUR AU - Lee, J. Y. AU - Kim, D. H. AU - Chung, Y. AU - Shin, S. U. AU - Kang, C. Y. PY - 2003 DA - 2003// TI - Comparison of the antitumor efficacies of Her-2/neu DNA vaccines inducing contrasting IgG immunity but comparable CTL activity in mice JO - Vaccine VL - 21 UR - https://doi.org/10.1016/S0264-410X(02)00470-X DO - 10.1016/S0264-410X(02)00470-X ID - Lee2003 ER - TY - JOUR AU - Firat, H. AU - Garcia-Pons, F. AU - Tourdot, S. AU - Pascolo, S. AU - Scardino, A. AU - Garcia, Z. AU - Michel, M. L. AU - Jack, R. W. AU - Jung, G. AU - Kosmatopoulos, K. PY - 1999 DA - 1999// TI - H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies JO - Eur J Immunol VL - 29 UR - https://doi.org/3.0.CO;2-Q DO - 3.0.CO;2-Q ID - Firat1999 ER - TY - JOUR AU - Carmon, L. AU - Bobilev-Priel, I. AU - Brenner, B. AU - Bobilev, D. AU - Paz, A. AU - Bar-Haim, E. AU - Tirosh, B. AU - Klein, T. AU - Fridkin, M. AU - Lemonnier, F. PY - 2002 DA - 2002// TI - Characterization of novel breast carcinoma-associated BA46-derived peptides in HLA-A2.1/D(b)-beta2 m transgenic mice JO - J Clin Invest VL - 110 UR - https://doi.org/10.1172/JCI200214071 DO - 10.1172/JCI200214071 ID - Carmon2002 ER - TY - JOUR AU - Alves, P. M. AU - Faure, O. AU - Graff-Dubois, S. AU - Gross, D. A. AU - Cornet, S. AU - Chouaib, S. AU - Miconnet, I. AU - Lemonnier, F. A. AU - Kosmatopoulos, K. PY - 2003 DA - 2003// TI - EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes JO - Cancer Res VL - 63 ID - Alves2003 ER - TY - JOUR AU - Machlenkin, A. AU - Paz, A. AU - Bar Haim, E. AU - Goldberger, O. AU - Finkel, E. AU - Tirosh, B. AU - Volovitz, I. AU - Vadai, E. AU - Lugassy, G. AU - Cytron, S. PY - 2005 DA - 2005// TI - Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-05-0133 DO - 10.1158/0008-5472.CAN-05-0133 ID - Machlenkin2005 ER - TY - JOUR AU - Gritzapis, A. D. AU - Voutsas, I. F. AU - Lekka, E. AU - Tsavaris, N. AU - Missitzis, I. AU - Sotiropoulou, P. AU - Perez, S. AU - Papamichail, M. AU - Baxevanis, C. N. PY - 2008 DA - 2008// TI - Identification of a novel immunogenic HLA-A*0201-binding epitope of HER-2/neu with potent antitumor properties JO - J Immunol VL - 181 UR - https://doi.org/10.4049/jimmunol.181.1.146 DO - 10.4049/jimmunol.181.1.146 ID - Gritzapis2008 ER - TY - JOUR AU - Lin, C. C. AU - Chou, C. W. AU - Shiau, A. L. AU - Tu, C. F. AU - Ko, T. M. AU - Chen, Y. L. AU - Yang, B. C. AU - Tao, M. H. AU - Lai, M. D. PY - 2004 DA - 2004// TI - Therapeutic HER2/Neu DNA vaccine inhibits mouse tumor naturally overexpressing endogenous neu JO - Mol Ther VL - 10 UR - https://doi.org/10.1016/j.ymthe.2004.05.015 DO - 10.1016/j.ymthe.2004.05.015 ID - Lin2004 ER - TY - JOUR AU - Pupa, S. M. AU - Iezzi, M. AU - Di Carlo, E. AU - Invernizzi, A. AU - Cavallo, F. AU - Meazza, R. AU - Comes, A. AU - Ferrini, S. AU - Musiani, P. AU - Menard, S. PY - 2005 DA - 2005// TI - Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination JO - Cancer Res VL - 65 ID - Pupa2005 ER - TY - JOUR AU - Gallo, P. AU - Dharmapuri, S. AU - Nuzzo, M. AU - Maldini, D. AU - Iezzi, M. AU - Cavallo, F. AU - Musiani, P. AU - Forni, G. AU - Monaci, P. PY - 2005 DA - 2005// TI - Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector JO - Int J Cancer VL - 113 UR - https://doi.org/10.1002/ijc.20536 DO - 10.1002/ijc.20536 ID - Gallo2005 ER - TY - JOUR AU - Li, L. AU - Boussiotis, V. A. PY - 2006 DA - 2006// TI - Physiologic regulation of central and peripheral T cell tolerance: lessons for therapeutic applications JO - J Mol Med VL - 84 UR - https://doi.org/10.1007/s00109-006-0098-5 DO - 10.1007/s00109-006-0098-5 ID - Li2006 ER - TY - JOUR AU - Palmer, E. PY - 2003 DA - 2003// TI - Negative selection--clearing out the bad apples from the T-cell repertoire JO - Nat Rev Immunol VL - 3 UR - https://doi.org/10.1038/nri1085 DO - 10.1038/nri1085 ID - Palmer2003 ER - TY - JOUR AU - Disis, M. L. AU - Gralow, J. R. AU - Bernhard, H. AU - Hand, S. L. AU - Rubin, W. D. AU - Cheever, M. A. PY - 1996 DA - 1996// TI - Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein JO - J Immunol VL - 156 ID - Disis1996 ER - TY - JOUR AU - Ko, H. J. AU - Kim, Y. J. AU - Kim, Y. S. AU - Chang, W. S. AU - Ko, S. Y. AU - Chang, S. Y. AU - Sakaguchi, S. AU - Kang, C. Y. PY - 2007 DA - 2007// TI - A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-06-4639 DO - 10.1158/0008-5472.CAN-06-4639 ID - Ko2007 ER - TY - JOUR AU - Baxevanis, C. N. AU - Sotiriadou, N. N. AU - Gritzapis, A. D. AU - Sotiropoulou, P. A. AU - Perez, S. A. AU - Cacoullos, N. T. AU - Papamichail, M. PY - 2006 DA - 2006// TI - Immunogenic HER-2/neu peptides as tumor vaccines JO - Cancer Immunol Immunother VL - 55 UR - https://doi.org/10.1007/s00262-005-0692-3 DO - 10.1007/s00262-005-0692-3 ID - Baxevanis2006 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/9/386/prepub UR - http://www.biomedcentral.com/1471-2407/9/386/prepub ID - ref33 ER -